EKF — EKF Diagnostics Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual income statement for EKF Diagnostics Holdings, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	81.8	66.6	52.6	50.2	51.6
Cost of Revenue
Gross Profit	39.4	30.8	24.4	24.4	26.5
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	60.1	75.6	50.5	43.9	44.6
Operating Profit	21.7	-8.97	2.08	6.26	6.98
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	21.4	-8.94	2.13	6.26	7.09
Provision for Income Taxes
Net Income After Taxes	16.2	-9.58	2.73	6.58	2.53
Minority Interest
Net Income Before Extraordinary Items
Net Income	15.9	-10.1	2.35	6.24	2.12
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15.9	-10.1	2.35	6.24	2.12
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.035	0.003	0.009	0.014	0.005
Dividends per Share